Tectonic Therapeutic (TECX) Share-based Compensation (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Share-based Compensation data on file, last reported at $3.2 million in Q1 2026.

• Share-based Compensation for Q1 2026 came in at $3.2 million, up 52.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.6 million (up 119.97% YoY), and the FY2025 annual result was $10.5 million, up 200.69% from the prior year.
• Share-based Compensation grew to $3.2 million in Q1 2026 per TECX's latest filing, from $3.0 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $3.4 million in Q1 2022 and troughed at $275000.0 in Q3 2023.
• A 5-year average of $2.0 million and a median of $2.3 million in 2022 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2023 and 2025: Share-based Compensation slumped 89.65% in 2023, then jumped 555.14% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $2.3 million in 2022, then sank by 86.96% to $294000.0 in 2023, then soared by 279.93% to $1.1 million in 2024, then jumped by 167.59% to $3.0 million in 2025, then increased by 7.23% to $3.2 million in 2026.
• Business Quant data shows TECX's Share-based Compensation at $3.2 million in Q1 2026, $3.0 million in Q4 2025, and $2.8 million in Q3 2025.